NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 312 filers reported holding NOVAVAX INC in Q3 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | +10.4% | 11,807 | +14.6% | 0.00% | 0.0% |
| Q2 2023 | $77 | +8.5% | 10,307 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $71 | -40.3% | 10,307 | -10.9% | 0.00% | -42.9% |
| Q4 2022 | $119 | -99.9% | 11,562 | +2.5% | 0.01% | -41.7% |
| Q3 2022 | $205,000 | -63.7% | 11,282 | +3.0% | 0.01% | -61.3% |
| Q2 2022 | $564,000 | -15.1% | 10,957 | +21.5% | 0.03% | +3.3% |
| Q1 2022 | $664,000 | -13.0% | 9,017 | +69.0% | 0.03% | -9.1% |
| Q4 2021 | $763,000 | -15.8% | 5,336 | +22.1% | 0.03% | -23.3% |
| Q3 2021 | $906,000 | +14.5% | 4,369 | +17.3% | 0.04% | +16.2% |
| Q2 2021 | $791,000 | +20.4% | 3,724 | +2.8% | 0.04% | +2.8% |
| Q1 2021 | $657,000 | +34.9% | 3,624 | -17.0% | 0.04% | -16.3% |
| Q4 2020 | $487,000 | +28.8% | 4,365 | +25.1% | 0.04% | +19.4% |
| Q3 2020 | $378,000 | -3.3% | 3,489 | -25.6% | 0.04% | -2.7% |
| Q2 2020 | $391,000 | – | 4,692 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 90,000 | $4,629,000 | 1.95% |
| Affinity Asset Advisors, LLC | 85,000 | $4,372,000 | 1.84% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,814 | $132,500,000 | 1.38% |
| Mendel Capital Management LLC | 23,835 | $1,226,000 | 1.37% |
| Faithward Advisors, LLC | 80,143 | $4,122,000 | 0.92% |
| Coatue Management | 1,241,716 | $63,861,000 | 0.77% |
| Rock Springs Capital Management LP | 475,100 | $24,434,000 | 0.71% |
| SECTOR GAMMA AS | 55,324 | $2,845,000 | 0.64% |
| SevenOneSeven Capital Management | 5,103 | $262,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 49,200 | $2,530,000 | 0.51% |